Brochure: Integrated bioprocessing
Posted: 1 April 2021 | Merck | No comments yet
The journey from large molecule to approved biotherapeutic is long, costly, complex, and fraught with risk – yet rewards for success are substantial.
Knowing what to expect and who and where to go for guidance can provide confidence, you’re on the right track and accelerate the journey. From bench to full-scale production, we offer a full range of raw materials, tools, services, and technologies, from off-the-shelf to customizable, to accelerate development, optimization and scale-up of your process. Our in-house experts have decades of bioprocessing experience and will collaborate with you to tackle any development and processing challenge, as well as provide guidance on regulatory expectations and testing requirements to meet your compliance needs.
Related content from this organisation
- Global bioreactor market to value over $16bn by 2027
- The big debate. Beyond the data and document distinction: how to transform life sciences experiences via improved information flow
- Brochure: Integrated bioprocessing
- Moving towards the digitalisation of your lab, with the 8th edition of the Paperless Lab Academy® – this year, online
- Gilead and Merck to collaborate on long-acting HIV treatments
Related topics
Biologics, Biopharmaceuticals, Bioprocessing, Biosimilars, Chromatography, Excipients, Formulation, Gene therapy, Good Manufacturing Practice (GMP), Manufacturing, Outsourcing
